eXoZymes, Inc. (EXOZ) vs OKYO Pharma Limited (OKYO)

A side-by-side comparison of eXoZymes, Inc. and OKYO Pharma Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

EXOZ

eXoZymes, Inc.

$51M

$5.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

OKYO

OKYO Pharma Limited

$56M

$1.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — EXOZ vs OKYO

growth of $100 · dividends reinvested · last 2y

EXOZ -36.2% (-20.1%/yr)OKYO +36.1% (+16.7%/yr)OKYO compounded faster over this window

EXOZ OKYO

EXOZ vs OKYO: by the numbers

•OKYO is the larger company ($56M vs $51M market cap).

Metrics side by side

Valuation

Metric	EXOZ	OKYO
P/B ratio	14.02	4.54

Profitability

Metric	EXOZ	OKYO
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	0.00%
ROE	-278.89%	-72.55%
ROIC	-157.40%	-68.91%

Go deeper

Full EXOZ analysis Full OKYO analysis Interactive comparison tool

Dig into the metrics

eXoZymes ROE OKYO Pharma ROE eXoZymes operating margin OKYO Pharma operating margin eXoZymes revenue growth OKYO Pharma revenue growth eXoZymes free cash flow OKYO Pharma free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.